Ridgemont Equity Partners
Sunvera Group Continues Expansion in Metro Detroit
October 27, 2020
Bingham Farms, MI (October 27, 2020) – Sunvera Group (“Sunvera”), a management services organization providing services to ophthalmology practices across multiple subspecialties and a Ridgemont Equity Partners portfolio company, announced the acquisition of Rohr Eye & Laser Center and welcomes Dr. Jeffrey Rohr to its growing team of eye care specialists.
Dr. Rohr is a fellowship trained refractive surgeon who specializes in advanced cataract and LASIK laser vision correction procedures. He is a clinical assistant professor at Michigan State University and provides comprehensive ophthalmology to the Grand Blanc, MI market and surrounding community. Dr. Rohr brings over 20 years of experience to Sunvera and will support additional growth of the company’s ophthalmology services offering in the Metro Detroit area. Financial terms of the transaction were not disclosed.
“We are excited to welcome Dr. Rohr to the Sunvera family,” said Greg Nodland, CEO of Sunvera Group. “This partnership broadens our geographic footprint in the Michigan market, allowing us to provide more access to patients while building our role as a market leader."
“Partnering with Sunvera Group represents an opportunity for me to join a collaborative, growing network of providers while maintaining autonomy over daily clinical operations,” said Dr. Jeffrey Rohr. “I am excited to join the Sunvera team and continue providing high-quality eye care services.”
McGuireWoods provided legal services to Sunvera. Footprint Capital served as buy-side advisor to Sunvera and continues to pursue additional acquisition targets in Michigan and throughout the Midwest.
About Sunvera Group
Sunvera Group is a management services organization providing ophthalmology services across multiple subspecialties.
About Ridgemont Equity Partners
Ridgemont Equity Partners is a Charlotte-based middle market buyout and growth equity investor. Since 1993, the principals of Ridgemont have invested over $5 billion. The firm focuses on equity investments up to $250 million and utilizes a proven, industry-focused investment approach and repeatable value creation strategies. Ridgemont’s most recent flagship fund, REP III, was formed in 2018 and has $1.65B of committed capital.